Dr. Georg Winter explores how chemical neomorphs can give proteins new functions by reshaping their cellular interactions, ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating ...

Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients ...

A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...

A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

BIO Capital continues support as founding investor, having backed Ray Therapeutics since seed funding in 2021 through Series ...

The Navy wants to buy the first Trump-class battleship in next year’s budget submission, a schedule that would allow the ...

Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...

Novel nasal spray therapy reduces brain inflammation and restores memory in ageing models, showing potential for future ...